Axcelis Technologies, Inc. — FY 2012 Form 10-K
Reporting period: Fiscal year ended December 31, 2012. This is an annual filing, not a standalone Q4 filing; quarterly figures below are included where disclosed. Axcelis designs, manufactures, and services semiconductor equipment, principally ion implanters, with aftermarket parts and services.
Financial performance and liquidity
| Metric | FY 2012 | FY 2011 |
|---|---|---|
| Revenue | $203.4 million | $319.4 million |
| Gross profit / margin | $58.2 million / 28.6% | $114.7 million / 35.9% |
| Operating income (loss) | $(30.9) million | $7.1 million |
| Net income (loss) | $(34.0) million; $(0.32) per share | $5.1 million; $0.05 per share |
| Operating cash flow | $(10.6) million | $3.5 million |
| Cash and cash equivalents at year-end | $45.0 million | $46.9 million |
| Working capital at year-end | $145.4 million | $164.6 million |
Capital expenditures were $0.6 million in 2012. Total liabilities were $36.1 million and stockholders’ equity was $186.1 million at year-end. No amounts were borrowed under the revolving credit facility during 2012; available capacity was $17.3 million under a facility of up to $30 million, and the company reported compliance with its covenants. The filing does not identify outstanding funded debt at year-end.
Q4 2012 revenue was $44.6 million, gross profit was $0.5 million, and net loss was $14.8 million. Q4 results included a $13.4 million inventory provision.
Material changes versus comparable periods
- Annual revenue fell 36.3% from 2011, primarily reflecting weaker semiconductor-equipment demand and lower customer capital spending. Product revenue declined 39.3%; service revenue declined 9.4%.
- Gross margin decreased to 28.6% from 35.9%. The company cited the inventory reserve, lower system volume and unfavorable fixed-cost absorption; higher-margin parts and upgrade mix partly offset these pressures.
- Aftermarket revenue declined to $124.1 million from $147.6 million, as lower fab utilization reduced demand for parts, upgrades and service.
- Cash used in operations was $10.6 million, versus $3.5 million generated in 2011. Cash decreased by $1.9 million overall, partly offset by $8.7 million of cash proceeds from the Lam transaction.
Outlook, management commentary, and risks
- Management expected industry conditions similar to 2012 to continue into 2013. It said current cash and cash equivalents should be sufficient for anticipated requirements, subject to sales and expense assumptions.
- In December 2012, Axcelis sold dry-strip assets and intellectual property to Lam Research for a stated purchase price of $10.7 million, including $2.0 million contingent on milestones. Axcelis received $8.7 million in 2012 and recorded a $7.9 million gain. The company plans to stop selling 300mm dry-strip equipment in September 2013, continue smaller-wafer sales through December 2015, and support its installed base indefinitely.
- Cost actions included workforce reductions, three weeks of unpaid shutdowns, and tighter discretionary spending. Restructuring charges were $4.2 million in 2012; a further first-quarter 2013 headcount reduction was expected to incur about $1.1 million of costs.
- Inventory reserves increased by $14.5 million during 2012; the year-end reserve was $33.6 million, compared with $22.8 million a year earlier. Management’s estimates depend on forecasts of demand, product life cycles and market conditions.
- Principal risks include semiconductor-industry cyclicality, significant customer concentration (the ten largest customers represented 70.6% of revenue), international exposure, competition and technology execution, sole- or limited-source suppliers, and potential additional liquidity needs if forecasts prove inaccurate. Backlog is limited and orders may be cancelled or rescheduled.
- The company recorded no long-lived-asset impairment after testing at year-end; the analysis relied on forecasts from its long-term strategic plan. It maintained a full valuation allowance on U.S. net deferred tax assets due to cumulative losses.
- Ernst & Young issued an unqualified opinion on the financial statements and internal control over financial reporting. Management also concluded disclosure controls were effective.
Important facts for investors to verify
- Whether semiconductor demand, system shipments and customer fab utilization recover as assumed, and how these affect revenue and operating cash flow.
- Whether further inventory write-downs, margin pressure or additional restructuring costs occur.
- Achievement and timing of Lam transaction milestones and contingent proceeds, and the financial impact of the dry-strip transition.
- Liquidity and covenant headroom: cash fell during 2012, while the revolving facility’s availability depends partly on receivables and compliance with financial covenants.
- Exposure to major customers and overseas markets, and whether customer concentration or foreign-exchange effects change materially.
- Revenue-recognition estimates, deferred system revenue, tax valuation allowances and the assumptions underlying the no-impairment conclusion.